![Elaine Hylek](https://d2ogjlfjkptkow.cloudfront.net/assets/img/board-member-default-image.png)
Elaine M Hylek MD, MPH
Professor of Medicine at Boston University School of Medicine, Boston, MAElaine M. Hylek, MD, MPH, is a Professor of Medicine at Boston University School of Medicine. She received her MD from the University of Pittsburgh School Of Medicine and a Masters in Public Health (quantitative methods) from Harvard University School of Public Health. She completed her residency training in internal medicine at Massachusetts General Hospital and Harvard Medical School in Boston, Massachusetts. Her research areas include arterial (stroke) and venous thrombosis, anticoagulant therapies, and atrial fibrillation. She has served as PI on several NIH R01 grants, served on the Executive Steering Committees for international clinical trials and national registries, Event Adjudication Committees, and Data Safety Monitoring Boards. She has also served as the Late Breaking Clinical Trial Discussant for multiple international trials in the field of thrombosis. Dr. Hylek is a Section Editor for Thrombosis and Haemostasis, a member of the International Society of Thrombosis and Haemostasis Executive Committee for World Thrombosis Day, and the Director of the Thrombosis and Anticoagulation Service at Boston Medical Center. She is extensively published and designated a U.S. News Top Doctor and voted Best Doctors in America for the past decade.
Disclosures
Dr. Hylek's Disclosures:- Consultant: Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Janssen, Medtronic, Myokardia, Pfizer
- Research: Abbott, Janssen